The findings were published in Science Robotics, showcasing the potential of integrating biological systems with robotic frameworks. The biohybrid hand operates using “MuMuTAs” (multiple muscle tissue ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference ...

Merger Completion: On August 15, 2024, Silexion completed its business combination with Moringa Acquisition Corp, becoming a ...

Researchers from the University of Tokyo and Waseda University in Japan have developed a biohybrid robot hand powered by ...

Scaling up biohybrid robots has been difficult due to the weak contractile force of lab-grown muscles, the risk of necrosis in thick muscle tissues, and the challenge of integrating biological ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S.

Patients with Crohn’s disease and spondyloarthritis have a unique composition of enteric bacteria that may differentiate them ...

Advancements in minimally invasive procedures have fueled industry growth, reducing hospital stays and post-operative recovery times. Furthermore, liposuction’s role in improving the quality of life ...

Briefly, the hFOB1.19 human osteoblasts were harvested ... These results further showed the inhibitory effect of N7G on femoral head necrosis and osteoblasts apoptosis. However, it is crucial to ...

Herpesvirus-encoded microRNAs (v-miRNAs) play a crucial role in modulating host cellular processes to promote viral persistence, immune evasion, and pathogenesis. These v-miRNAs function by targeting ...

Fat necrosis refers to dead or damaged breast tissue that often manifests as a noncancerous lump under the skin. In most cases, these lumps go away on their own and don’t return. Fat necrosis of ...

Human beings can’t be fully understood through a single discipline. This unique BSc allows you to combine life sciences with social and historical sciences to pursue your own lines of enquiry – and ...